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Dear Sir,
New Delhi metallo- -lactamase␤ producing Enterobacteriaceae
are a serious threat to the public health sectors world-
wide. NDM producing pathogens generally display resistance
against several different classes of antibiotics including car-
bapenems; considered last resort to treat infections caused
by such pathogens.1,2 Until now 19 NDM variants (NDM-1 to
NDM-19) have been identiﬁed from different parts of the world
http://www.lahey.org/Studies/other.asp . NDM-4 differs from
NDM-1 by a single point mutation at position 154 (M–L) and
is associated with high carbapenemase activity.3 We are ﬁrst
time reporting the description of NDM-4 producing Escherichia
coli isolated from urine sample in Pakistan.
A 4-year-old female patient was hospitalized in a tertiary
care hospital Lahore, Pakistan in March 2014. After admis-
sion, her urine culture revealed the presence of E. coli which
was conﬁrmed by VITEK
®
2 system (bioMerieux, France)
and MALDI-TOF (Bruker, Germany). Isolate was also car-
bapenemase and metallo- -lactamase␤ producer identiﬁed
by modiﬁed Hodge’s test and double disk synergy method
respectively.4 Minimum inhibitory concentration ( g/mL)␮
of antibiotics using GN XN05 card in VITEK
®
2 compact
system (bioMerieux, France) displayed pan-drug resistance
to commonly used antibiotics including meropenem and
only effective drug was colistin. Furthermore, colistin
susceptibility was determined by broth microdilution assay
Table 1 – MIC ( g/mL)␮ of NDM-4 producing Escherichia coli.
Isolates SAM PIP CXM CXA CFM CRO FEP ATM MEM LEV MXF MNO TE TMP C TGC CS
NDM-4
producing E. coli
≥32 ≥128 ≥64 ≥64 ≥4 ≥64 ≥64 ≥64 ≥16 ≥8 ≥8 ≥16 ≥16 ≥16 ≥64 4 1
SAM: ampicillin/sulbactam, PIP: piperacillin, CXM: cefuroxime, CXA: cefuroxime axetil, CFM: ceﬁxime, CRO: ceftriaxone, FEP: cefepime, ATM:
aztreonam, MEM: meropenem, LEV: levoﬂoxacin, MXF: moxiﬂoxacin, MNO: minocycline, TE: tetracycline, TMP: trimethoprim, C: chlorampheni-
col, TGC: tigecycline, CS: colistin.
in 96 microtiter Plate5 (Table 1). A previous study reported
that NDM-4 producing bacteria has higher MIC ( g/mL)␮
and hydrolytic activity as compared to NDM-1 producing
bacteria.3 Genotyping of blaNDM-4 was accomplished by PCR
(NDM-F-TGGCTTTTGAAACTGTCGCACC, NDM-R- CTGTCA-
CATCGAAATCGCGCGA) and DNA sequence analysis. Plasmid
characterization was performed as previously reported.4 S1
nuclease pulse ﬁeld gel electrophoresis and in gel DNA
hybridization revealed the presence of blaNDM-4 on 120 kb of
plasmid (data not shown). As per Carratoli6 procedure of plas-
mid typing, the isolate contained the Incompatible FII group of
plasmids. Multilocus sequence typing (MLST) was performed
as described earlier and E. coli belonged to the sequence type
(ST) 405.7 ST405 NDM producing E. coli has also been isolated
from two inpatients in Italy.8 It is documented that the Indian
sub-continent is the main reservoir and source of NDM pro-
ducing bacteria globally. Present study also supported this fact
in that the patient had no previous travel history. Moreover,
NDM-4 producing E. coli has also been reported from different
parts of the world including India and Italy.3,8 This study indi-
cates, the emergence of NDM-4 producing E. coli ST405 which
can lead to therapeutic failure and deaths particularly in chil-
dren. This isolate could be transferred through risk factors
such as bed sharing, substandard infection control practices
and most importantly urinary catheters.
The blaNDM containing IncFII plasmids might have become
the common vehicle for the spread of various NDM alleles
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among Enterobacteriaceae. Furthermore, they could also play a
relevant rolein the spread of such strains and other resistance
genes, especially if the isolate is present as part of the dom-
inant microbiota and the hygienic conditions are suboptimal
particularly in low-resource settings.
Nucleotide sequence accession number: The nucleotide
sequence of blaNDM-4 producing E. coli strain has been
deposited in the BankIt/GenBank/NCBI data base under acces-
sion number KY912035.
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